cutting-edge uk trials for mesothelioma: double immuno, arginine depletion and molecular profiling
Published 6 years ago • 522 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:14
atomic: treating mesothelioma with an arginine-degrading enzyme and combination chemotherapy
-
4:47
mesothelioma surgical trial updates in the uk: mars2 and mesotrap
-
0:56
targeting the tumor vasculature in mesothelioma
-
4:44
confirm trial: nivolumab in relapsed malignant mesothelioma
-
1:33
exciting randomized trials for mesothelioma: checkpoint inhibitor monotherapies and vinorelbine
-
1:13
mesothelioma biology: key genes and therapeutic targeting
-
0:50
checkpoint inhibition in mesothelioma: the confirm trial
-
18:08
new treatment avenues in malignant mesothelioma
-
7:01
mesothelioma: clinical trials and immunotherapy
-
0:43
mesothelioma: the key unanswered question
-
1:36
the future of arginine deprivation therapy in lung cancer
-
7:17
colorectal health & the faecal immunochemical test (fit) kit | we need to talk about this
-
1:27
mtesr™1: standardized medium for the feeder-independent maintenance of hescs & hipscs
-
2:39
mist: parp inhibitors for malignant mesothelioma
-
2:18
somagen® meshed, allograft dermal matrix: from donor to recipient
-
4:22
immunotherapy treatments for mesothelioma (complete guide)
-
4:11
mesothelioma data at asco 2020
-
2:59
promise-meso: pembrolizumab vs. standard chemotherapy for mesothelioma
-
1:34
personalized therapy in thoracic malignancies